Replication of sialodacryoadenitis virus in mouse L-2 cells

Researchers have long struggled to propagate the sialodacryoadenitis virus due to a lack of suitable continuous cell lines. This limitation has hindered efforts to study the pathogen in controlled laboratory settings. Prior research has shown that existing options for viral cultivation often yield insufficient quantities for detailed analysis. That uncertainty drove the need to identify more effective host systems for viral replication. No prior work had resolved the specific suitability of various mouse-derived cells for this purpose. Scientists previously relied on less efficient methods that restricted the scope of experimental investigations. This gap motivated the current search for a robust platform to support high-titer viral growth. The investigation addresses these historical challenges by evaluating potential cell lines for improved viral propagation.

The primary aim of this research was to compare the ability of the sialodacryoadenitis virus to replicate in different permanent cell lines. The study specifically investigated whether mouse-derived cells could support the growth of this rat-associated pathogen. Researchers sought to address the lack of widely available cell lines capable of producing high titers of the virus. This limitation has historically restricted the ability to conduct comprehensive studies on the virus. The team hypothesized that identifying a suitable host would improve the efficiency of viral cultivation. They focused on evaluating LBC, L-929, and L-2 cells to determine their respective capacities for viral propagation. The motivation for this work was to establish a reliable system for generating sufficient viral material for experimental purposes. By testing these specific lines, the authors intended to provide a new tool for the scientific community.

The investigators performed a comparative analysis of viral growth across three distinct permanent cell lines. They evaluated the LBC line, which is derived from rats, alongside two mouse-origin lines, L-929 and L-2. The team subjected the virus to repeated passages to assess its adaptability to these different environments. They monitored the cultures for signs of cytopathic effect to determine successful infection. The researchers quantified viral infectivity by measuring the concentration of infectious particles within the culture fluid. They also confirmed the presence of viral antigens and particles using standard laboratory techniques. The study included an in vivo component where susceptible rats received inoculations to verify the pathogenicity of the cultured virus. This systematic approach ensured a thorough assessment of the suitability of each cell line for viral propagation.

The L-2 cell line yielded the highest concentrations of the virus, reaching 10^8.0 infectious particles per 0.25 milliliters of culture fluid at 48 hours. This result represents a significant improvement over the LBC cell line, which produced titers one to two logs lower. The virus could be readily propagated in both LBC and L-2 cells following repeated passages. In contrast, the L-929 cell line failed to support the growth of the virus under the same conditions. Direct adaptation to L-2 cells also enabled successful propagation in LBC cells, but not in L-929 cells. The researchers successfully demonstrated the presence of viral antigen, particles, and cytopathic effects in both LBC and L-2 cultures. Inoculation of rats with the eighth passage of L-2 adapted virus resulted in the development of typical disease lesions. These findings confirm that the virus can be recovered from infected tissues and re-propagated in L-2 cells.

The findings demonstrate that the L-2 cell line serves as a highly effective host for propagating this specific coronavirus. Researchers suggest that this system allows for the production of significantly higher viral titers compared to previous methods. The study confirms that virus adapted to these cells remains infectious and capable of inducing characteristic disease symptoms in rats. These results provide a practical solution for overcoming previous limitations in viral cultivation. The authors propose that this tool will facilitate future comparative studies involving related murine coronaviruses. The evidence supports the use of this specific cell line for generating sufficient viral material for experimental use. The team concludes that the ability to grow the virus in a widely accessible line will advance ongoing research efforts. This work establishes a new standard for the laboratory maintenance of this pathogen.